United States Plasma Protein Therapeutics Market by Manufacturers, States, Type and Application, Forecast to 2022

Publisher Name :
Date: 05-Dec-2017
No. of pages: 119

"Plasma Protein Therapeutics is use blood products to treat disease.

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product."

Scope of the Report:

This report focuses on the Plasma Protein Therapeutics in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

  • Shire (Baxalta)

  • CSL

  • Grifols

  • Octapharma

  • Kedrion

  • LFB Group

  • Biotest

  • BPL

  • RAAS

  • CBPO

  • Hualan Bio

  • Kamada

Market Segment by States, covering

  • California

  • Texas

  • New York

  • Florida

  • Illinois

Market Segment by Type, covers

  • Coagulation Factor

  • Immune Globulin

  • Albumin

  • Other

Market Segment by Applications, can be divided into

  • Hemophilia

  • PID

  • Other

There are 17 Chapters to deeply display the United States Plasma Protein Therapeutics market.

Chapter 1, to describe Plasma Protein Therapeutics Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Plasma Protein Therapeutics, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Plasma Protein Therapeutics, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Plasma Protein Therapeutics market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Plasma Protein Therapeutics Research Findings and Conclusion, Appendix, methodology and data source.

United States Plasma Protein Therapeutics Market by Manufacturers, States, Type and Application, Forecast to 2022

Table of Contents

1 Market Overview
1.1 Plasma Protein Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Coagulation Factor
1.2.2 Immune Globulin
1.2.3 Albumin
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Hemophilia
1.3.2 PID
1.3.3 Other
1.4 Market Analysis by States
1.4.1 California Status and Prospect (2012-2022)
1.4.2 Texas Status and Prospect (2012-2022)
1.4.3 New York Status and Prospect (2012-2022)
1.4.4 Florida Status and Prospect (2012-2022)
1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Shire (Baxalta)
2.1.1 Profile
2.1.2 Plasma Protein Therapeutics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Shire (Baxalta) News
2.2 CSL
2.2.1 Profile
2.2.2 Plasma Protein Therapeutics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 CSL Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 CSL News
2.3 Grifols
2.3.1 Profile
2.3.2 Plasma Protein Therapeutics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Grifols Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Grifols News
2.4 Octapharma
2.4.1 Profile
2.4.2 Plasma Protein Therapeutics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Octapharma Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Octapharma News
2.5 Kedrion
2.5.1 Profile
2.5.2 Plasma Protein Therapeutics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Kedrion Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Kedrion News
2.6 LFB Group
2.6.1 Profile
2.6.2 Plasma Protein Therapeutics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 LFB Group Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 LFB Group News
2.7 Biotest
2.7.1 Profile
2.7.2 Plasma Protein Therapeutics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Biotest Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Biotest News
2.8 BPL
2.8.1 Profile
2.8.2 Plasma Protein Therapeutics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 BPL Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 BPL News
2.9 RAAS
2.9.1 Profile
2.9.2 Plasma Protein Therapeutics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 RAAS Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 RAAS News
2.10 CBPO
2.10.1 Profile
2.10.2 Plasma Protein Therapeutics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 CBPO Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.4 Business Overview
2.10.5 CBPO News
2.11 Hualan Bio
2.11.1 Profile
2.11.2 Plasma Protein Therapeutics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11.4 Business Overview
2.11.5 Hualan Bio News
2.12 Kamada
2.12.1 Profile
2.12.2 Plasma Protein Therapeutics Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Kamada Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12.4 Business Overview
2.12.5 Kamada News

3 United States Plasma Protein Therapeutics Market Competition, by Manufacturer
3.1 United States Plasma Protein Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Plasma Protein Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Plasma Protein Therapeutics Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Plasma Protein Therapeutics Manufacturer Market Share
3.4.2 Top 5 Plasma Protein Therapeutics Manufacturer Market Share
3.5 Market Competition Trend

4 United States Plasma Protein Therapeutics Market Analysis by States
4.1 United States Plasma Protein Therapeutics Sales Market Share by States
4.2 United States Plasma Protein Therapeutics Sales by States (2012-2017)
4.3 United States Plasma Protein Therapeutics Revenue (Value) by States (2012-2017)

5 United States Market Segmentation Plasma Protein Therapeutics by Type
5.1 United States Plasma Protein Therapeutics Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 United States Plasma Protein Therapeutics Sales and Market Share by Type (2012-2017)
5.1.2 United States Plasma Protein Therapeutics Revenue and Market Share by Type (2012-2017)
5.2 Coagulation Factor Sales Growth and Price
5.2.1 United States Coagulation Factor Sales Growth (2012-2017)
5.2.2 United States Coagulation Factor Price (2012-2017)
5.3 Immune Globulin Sales Growth and Price
5.3.1 United States Immune Globulin Sales Growth (2012-2017)
5.3.2 United States Immune Globulin Price (2012-2017)
5.4 Albumin Sales Growth and Price
5.4.1 United States Albumin Sales Growth (2012-2017)
5.4.2 United States Albumin Price (2012-2017)
5.5 Other Sales Growth and Price
5.5.1 United States Other Sales Growth (2012-2017)
5.5.2 United States Other Price (2012-2017)

6 United States Market Segmentation Plasma Protein Therapeutics by Application
6.1 United States Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
6.2 Hemophilia Sales Growth (2012-2017)
6.3 PID Sales Growth (2012-2017)
6.4 Other Sales Growth (2012-2017)

7 California Plasma Protein Therapeutics Sales, Revenue, by Type, Application and Manufacturers
7.1 California Plasma Protein Therapeutics Revenue, Sales and Growth Rate (2012-2017)
7.2 California Plasma Protein Therapeutics Sales and Market Share by Type
7.3 California Plasma Protein Therapeutics Sales by Application (2012-2017)

8 New York Plasma Protein Therapeutics Sales, Revenue, by Type, Application and Manufacturers
8.1 New York Plasma Protein Therapeutics Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Plasma Protein Therapeutics Sales and Market Share by Type
8.3 New York Plasma Protein Therapeutics Sales by Application (2012-2017)

9 Texas Plasma Protein Therapeutics Sales, Revenue, by Type, Application and Manufacturers
9.1 Texas Plasma Protein Therapeutics Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Plasma Protein Therapeutics Sales and Market Share by Type
9.3 Texas Plasma Protein Therapeutics Sales by Application (2012-2017)

10 Florida Plasma Protein Therapeutics Sales, Revenue, by Type, Application and Manufacturers
10.1 Florida Plasma Protein Therapeutics Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Plasma Protein Therapeutics Sales and Market Share by Type
10.3 Florida Plasma Protein Therapeutics Sales by Application (2012-2017)

11 Illinois Plasma Protein Therapeutics Sales, Revenue, by Type, Application and Manufacturers
11.1 Illinois Plasma Protein Therapeutics Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Plasma Protein Therapeutics Sales and Market Share by Type
11.3 Illinois Plasma Protein Therapeutics Sales by Application (2012-2017)

12 Plasma Protein Therapeutics Market Forecast (2017-2022)
12.1 United States Plasma Protein Therapeutics Sales, Revenue and Growth Rate (2017-2022)
12.2 Plasma Protein Therapeutics Market Forecast by States (2017-2022)
12.3 Plasma Protein Therapeutics Market Forecast by Type (2017-2022)
12.4 Plasma Protein Therapeutics Market Forecast by Application (2017-2022)

13 Plasma Protein Therapeutics Manufacturing Cost Analysis
13.1 Plasma Protein Therapeutics Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Price Trend of Key Raw Materials
13.1.3 Key Suppliers of Raw Materials
13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.2.1 Raw Materials
13.2.2 Labor Cost
13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Plasma Protein Therapeutics

14 Industrial Chain, Sourcing Strategy and Downstream Buyers
14.1 Plasma Protein Therapeutics Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2016
14.4 Downstream Buyers

15 Sales Channel, Distributors, Traders and Dealers
15.1 Sales Channel
15.1.1 Direct Marketing
15.1.2 Indirect Marketing
15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source

List of Tables and Figures

Figure Plasma Protein Therapeutics Picture
Table Product Specifications of Plasma Protein Therapeutics
Figure United States Sales Market Share of Plasma Protein Therapeutics by Types in 2016
Table Types of Plasma Protein Therapeutics
Figure Coagulation Factor Picture
Table Major Manufacturers of Coagulation Factor
Figure Immune Globulin Picture
Table Major Manufacturers of Immune Globulin
Figure Albumin Picture
Table Major Manufacturers of Albumin
Figure Other Picture
Table Major Manufacturers of Other
Table United States Plasma Protein Therapeutics Sales Market Share by Applications in 2016
Table Applications of Plasma Protein Therapeutics
Figure Hemophilia Picture
Figure PID Picture
Figure Other Picture
Figure California Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Plasma Protein Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Table Shire (Baxalta) Basic Information, Manufacturing Base and Competitors
Table Shire (Baxalta) Plasma Protein Therapeutics Type and Applications
Table Shire (Baxalta) Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Plasma Protein Therapeutics Type and Applications
Table CSL Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Plasma Protein Therapeutics Type and Applications
Table Grifols Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Octapharma Basic Information, Manufacturing Base and Competitors
Table Octapharma Plasma Protein Therapeutics Type and Applications
Table Octapharma Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kedrion Basic Information, Manufacturing Base and Competitors
Table Kedrion Plasma Protein Therapeutics Type and Applications
Table Kedrion Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table LFB Group Basic Information, Manufacturing Base and Competitors
Table LFB Group Plasma Protein Therapeutics Type and Applications
Table LFB Group Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biotest Basic Information, Manufacturing Base and Competitors
Table Biotest Plasma Protein Therapeutics Type and Applications
Table Biotest Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BPL Basic Information, Manufacturing Base and Competitors
Table BPL Plasma Protein Therapeutics Type and Applications
Table BPL Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table RAAS Basic Information, Manufacturing Base and Competitors
Table RAAS Plasma Protein Therapeutics Type and Applications
Table RAAS Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CBPO Basic Information, Manufacturing Base and Competitors
Table CBPO Plasma Protein Therapeutics Type and Applications
Table CBPO Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio Plasma Protein Therapeutics Type and Applications
Table Hualan Bio Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kamada Basic Information, Manufacturing Base and Competitors
Table Kamada Plasma Protein Therapeutics Type and Applications
Table Kamada Plasma Protein Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Plasma Protein Therapeutics Sales by Manufacturer (2016-2017)
Figure United States Plasma Protein Therapeutics Sales Market Share by Manufacturer in 2016
Figure United States Plasma Protein Therapeutics Sales Market Share by Manufacturer in 2017
Table United States Plasma Protein Therapeutics Revenue by Manufacturer (2016-2017)
Figure United States Plasma Protein Therapeutics Revenue Market Share by Manufacturer in 2015
Figure United States Plasma Protein Therapeutics Revenue Market Share by Manufacturer in 2016
Table United States Plasma Protein Therapeutics Price by Manufacturers (2016-2017)
Figure Top 3 Plasma Protein Therapeutics Manufacturer Market Share in 2016
Figure Top 3 Plasma Protein Therapeutics Manufacturer Market Share in 2017
Figure Top 5 Plasma Protein Therapeutics Manufacturer Market Share in 2016
Figure Top 5 Plasma Protein Therapeutics Manufacturer Market Share in 2017
Figure United States Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table United States Plasma Protein Therapeutics Sales by States (2012-2017)
Table United States Plasma Protein Therapeutics Sales Market Share by States (2012-2017)
Figure United States 2012 Plasma Protein Therapeutics Sales Market Share by States
Figure United States 2016 Plasma Protein Therapeutics Sales Market Share by States
Figure United States Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Table United States Plasma Protein Therapeutics Revenue by States (2012-2017)
Table United States Plasma Protein Therapeutics Revenue Market Share by States (2012-2017)
Table United States 2012 Plasma Protein Therapeutics Revenue Market Share by States
Table United States 2016 Plasma Protein Therapeutics Revenue Market Share by States
Table United States Plasma Protein Therapeutics Sales by Type (2012-2017)
Table United States Plasma Protein Therapeutics Sales Share by Type (2012-2017)
Table United States Plasma Protein Therapeutics Revenue by Type (2012-2017)
Table United States Plasma Protein Therapeutics Revenue Share by Type (2012-2017)
Figure United States Coagulation Factor Sales Growth (2012-2017)
Figure United States Coagulation Factor Price (2012-2017)
Figure United States Immune Globulin Sales Growth (2012-2017)
Figure United States Immune Globulin Price (2012-2017)
Figure United States Albumin Sales Growth (2012-2017)
Figure United States Albumin Price (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure United States Other Price (2012-2017)
Table United States Plasma Protein Therapeutics Sales by Application (2012-2017)
Table United States Plasma Protein Therapeutics Sales Share by Application (2012-2017)
Figure United States Hemophilia Sales Growth (2012-2017)
Figure United States PID Sales Growth (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure California Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Figure California Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table California Plasma Protein Therapeutics Sales by Type (2012-2017)
Table California Plasma Protein Therapeutics Sales Market Share by Type (2012-2017)
Table California Plasma Protein Therapeutics Sales by Application (2012-2017)
Table California Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure New York Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Figure New York Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table New York Plasma Protein Therapeutics Sales by Type (2012-2017)
Table New York Plasma Protein Therapeutics Sales Market Share by Type (2012-2017)
Table New York Plasma Protein Therapeutics Sales by Application (2012-2017)
Table New York Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure Texas Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Figure Texas Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table Texas Plasma Protein Therapeutics Sales by Type (2012-2017)
Table Texas Plasma Protein Therapeutics Sales Market Share by Type (2012-2017)
Table Texas Plasma Protein Therapeutics Sales by Application (2012-2017)
Table Texas Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure Florida Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Figure Florida Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table Florida Plasma Protein Therapeutics Sales by Type (2012-2017)
Table Florida Plasma Protein Therapeutics Sales Market Share by Type (2012-2017)
Table Florida Plasma Protein Therapeutics Sales by Application (2012-2017)
Table Florida Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure Illinois Plasma Protein Therapeutics Revenue and Growth (2012-2017)
Figure Illinois Plasma Protein Therapeutics Sales and Growth (2012-2017)
Table Illinois Plasma Protein Therapeutics Sales by Type (2012-2017)
Table Illinois Plasma Protein Therapeutics Sales Market Share by Type (2012-2017)
Table Illinois Plasma Protein Therapeutics Sales by Application (2012-2017)
Table Illinois Plasma Protein Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Plasma Protein Therapeutics Sales, Revenue and Growth Rate (2017-2022)
Table United States Plasma Protein Therapeutics Sales Forecast by States (2017-2022)
Table United States Plasma Protein Therapeutics Market Share Forecast by States (2017-2022)
Table United States Plasma Protein Therapeutics Sales Forecast by Type (2017-2022)
Table United States Plasma Protein Therapeutics Market Share Forecast by Type (2017-2022)
Table United States Plasma Protein Therapeutics Sales Forecast by Application (2017-2022)
Table United States Plasma Protein Therapeutics Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Plasma Protein Therapeutics
Figure Manufacturing Process Analysis of Plasma Protein Therapeutics
Figure Plasma Protein Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Plasma Protein Therapeutics Major Manufacturers in 2016
Table Major Buyers of Plasma Protein Therapeutics
Table Distributors/Traders/ Dealers List
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 35
    Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) pipel......
  • Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 37
    Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018 Summary Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Transglutaminase 2 (TG2) is a member of the transglutaminase family tha......
  • Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 40
    Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018 Summary Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Respiratory syncytial virus G protein is a protein produced by respiratory syncytial virus. It attaches the virion to the host cell membrane by interacting with heparan sulfate. It interacts with host CX3CR1, the receptor for the CX3C chemokine fractalkine, to modulate the immune response and facilitate in......
  • Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 70
    Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018 Summary Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) pipeline Target constitutes close to 15 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Survival Motor Neuron Protein - Pipeline Review, H2 2018, outlays comprehensive information on the S......
  • NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 65
    NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'NT 3 Growth Factor Receptor - Pipeline Review, H2 2018'; NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) pipeline Target constitutes close to 7 molecules. ......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs